• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    The Anti-Depressant Pack
    February 14, 2017
    200:1 SAMPLES
    May 19, 2017

    THUNDER

    Rated 5.00 out of 5 based on 11 customer ratings
    (11 customer reviews)

    $250.00

    Clear
    SKU: N/A Category: Featured Tag: Featured
    Share
    0
    • Description
    • Additional information
    • Reviews (11)
    THUNDER
    200:1 STRENGTH VERY POTENT

    Proprietary herbal blend for men.

    Apigenin
    Apigenin
    Arugula
    Arugula
    Beet
    Beet
    Butea superba
    Butea superba
    Cacao
    Cacao
    Carnosine
    Passion flower
    Passion flower
    Citrus sinensis
    Citrus sinensis

    Damiana

    Damiana

    Epimedium sagittatum

    Epimedium sagittatum

    Ginseng

    Ginseng

    Grapefruit

    Grapefruit

    Gynostemma

    Gynostemma

    Icarrin

    IcarIin

    Kaempferia parviflor

    Kaempferia parviflor

    Maca

    Maca

    Moringa oleifera
    Moringa oleifera
    Pomegranate
    Pomegranate
    Quercetin
    Quercetin
    Resveratrol
    Resveratrol
    Rubus coreanus
    Rubus coreanus

    Ruta chalepensis

    Ruta chalepensis

    Rutin

    Rutin

     

    Scutellaria baicalensis

    Scutellaria baicalensis

    Sophora flavescens

    Sophora flavescens

    Tongcat Ali

    Tongcat Ali

     

    Warnings

    As with any supplement, consult your medical practitioner prior to using this product if you are pregnant, may become pregnant, breastfeeding, taking medication, other dietary supplements or have a medical condition.

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    *Daily Value has not been established



     

    … -07 USE OF STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION: EVALUATION OF CLINICAL …

    … -07-008 Exploring the number of low intensity shock wave treatment (LiSWT) sessions needed in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): 6 vs …

    … -08 LONGITUDINAL RISK OF DEVELOPING CARDIO VASCULAR DISEASES AMONG PATIENTS WITH ERECTILE DYSFUNCTION-WHICH PATIENTS DESERVE …

    … -label, Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra (R)(Sildenafil Citrate) in Males with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

    … -S&T-15 THE RELATIONSHIP BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG THE VASCULOGENIC ERECTILE DYSFUNCTION …

    … -term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive PULMONARY disease) on concurrent erectile dysfunction

    … ‐rated patient preference and patient‐and partner‐rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ …

    … , and ERECTILE DYSFUNCTION in congestive HEART failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction

    … , Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra®(Sildenafil Citrate) in Korean Men with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

    … : EXPLORATION OF THE ASSOCIATION BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG VASCULOGENIC ERECTILE DYSFUNCTION …

    … : metode za očuvanje protoka Kroz unutrašnju ilijačnu arteriju.[Endo VASCULAR treatment of aortoiliac aneurysms (EVAR) and erectile dysfunction: methods to preserve …

    … : POOLED ANALYSIS OF SATISFACTION WITH VARDENAFIL TREATMENT IN MEN WITH ERECTILE DYSFUNCTION AND THEIR PARTNERS

    … . FTY720 supplementation partially improves ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and …

    … . J Sex Med 2007; 4: 226–30. This article was inadvertently listed as a Case Report. It should have been listed as Original Research—Erectile Dysfunction.

    … ‘SEXUAL DYSFUNCTIONS: Women’s Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized …

    … /hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with ERECTILE DYSFUNCTION and improves arterial …

    … ®) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

    … 6.5. Prevalenta disfunctiei erectile la pacientii de sex masculin cu accident VASCULAR cerebral, factori de risc si co-morbiditati asociate/Prevalence of erectile dysfunction …

    … and 6-month durability of endo VASCULAR pelvic arterial re VASCULAR ization in alleviating lower urinary tract symptoms and ERECTILE DYSFUNCTION in patients with …

    … and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 476 Patients with Erectile Dysfunction: Implications for Endo VASCULAR  …

    … AND INCREASED AORTIC STIFFNESS AND PENILE VASCULAR DISEASE SEVERITY IN ERECTILE DYSFUNCTION PATIENTS WITH METABOLIC …

    … AND INFLAMMATION IN CORPUS CAVERNOSUM ARE INCREASED COMPARED TO ARM BLOOD LEVEL: IMPACT ON ERECTILE DYSFUNCTION

    … and Partial Bladder Outlet Obstructed Rabbit Corpus Cavernosal Contractility: Modulation of Nitric Oxide-mediated Relaxation and Relevance to Erectile Dysfunction

    … and stem cell therapy in the treatment of ERECTILE DYSFUNCTION and PULMONARY HYPERTENSION ; potential treatments for the common problem of endothelial dysfunction

    … AND WAVE REFLECTIONS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

    … ARTERIAL STIFFENING AND WAVE REFLECTIONS IN DIABETES: THE EFFECTS OF AUTONOMIC NEUROPATHY AND ERECTILE DYSFUNCTION

    … ARTERY CALCIFICATIONS IN HEMODIALYSIS PATIENTS AND ITS CORRELATION WITH THE PREVALENCE OF ERECTILE DYSFUNCTION

    … artery peak systolic velocity among normal adults in Abuja, Nigeria: A Baseline parameter for sonographic diagnosis of VASCULOGENIC erectile dysfunction

    … Assessment of Prevalence and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in Patients with Erectile Dysfunction

    … assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s …

    … Association Between Aortic Stiffness, Wave Reflections, and Duration of VASCULOGENIC Erectile Dysfunction: Linking ERECTILE DYSFUNCTION With Generalized VASCULAR  …

    … Association of the T-786C, G894T and 4a/4b Polymorphisms of the Endothelial Nitric Oxide Synthase Gene with VASCULOGENIC ERECTILE DYSFUNCTION in Iranian Subjects

    … between arterial stiffness, left ventricular geometry and the severity of erectile dysfunction: A ventriculoarterial interaction in ERECTILE DYSFUNCTION patients

    … between the venous shunts of penile corpus spongiosum and cavernous compartments during erection used in the pharmacotherapy of erectile dysfunction.

    … C-reactive protein are complementary determinants of global arterial function and early structural changes in HYPERTENSIVE males with erectile dysfunction

    … cavernosal ARTERY intima-media thickness in patients with erectile dysfunction. A new parameter in the diagnosis of VASCULAR erectile dysfunction. Our experience on 59 …

    … CELLS AND REDUCES ENDOTHELIAL INFLAMMATORY MARKERS IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK

    … characterization of population with ERECTILE DYSFUNCTION and analysis of its CARDIO VASCULAR risk factors and degree of ERECTILE DYSFUNCTION in a quaternary center

    … COURSE OF TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

    … crossover, placebo‐controlled comparative clinical trial of arginine aspartate plus adenosine monophosphate for the intermittent treatment of male erectile dysfunction

    … Dimethylamini-Hydrolase Causes Elevation of Asymmetric Dimethyl Arginine in Atherosclerotic Rat Model of VASCULOGENIC Erectile Dysfunction

    … displayer) for audiovisual sexual stimulation after oral phosphodiesterase type 5 (PDE 5) inhibitor medication for the diagnosis of VASCULOGENIC erectile dysfunction

    … DOPPLER ULTRASOUND AS A DIAGNOSTIC TOOL FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR VASCULOGENIC ERECTILE DYSFUNCTION

    … duplex ultrasonography in men with Peyronie’s disease: Is it veno‐occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?

    … DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION

    … editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease …

    … embolization of an arteriovenous fistula from the arteria bulbi penis to the corpus spongiosum penis in the treatment of erectile dysfunction: normal function regained …

    … entitled “Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC erectile dysfunction: a triplex ultrasonography …

    … Erectile dysfunction shock wave therapy (EDSWT) improves hemodynamic parameters in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): A triplex …

    … EVALUATION OF ARTERIAL STIFFNESS AND CARDIAC FUNCTION IN PATIENTS WITH VASCULAR ERECTILE DYSFUNCTION, ACUTE EFFECTS OF …

    … EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR FOR POTENTIAL USE IN THE TREATMENT OF NEURO VASCULAR ERECTILE DYSFUNCTION

    … expression of VASCULAR endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction …

    … FOR IDENTIFYING WALL MOTION ABNORMALITIES DURING STRESS TEST IN ERECTILE DYSFUNCTION HYPERTENSIVE MEN: COMPARISON OF …

    … from a database of 48 million men in the United States: Relationship of CARDIO VASCULAR disease, diabetes mellitus and depression with age and erectile dysfunction

    … FUNCTION OF CAVERNOUS ARTERIES CORRELATES WITH ITS CLINCAL EFFICACY IN PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION

    … growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and VASCULOGENIC ERECTILE DYSFUNCTION induced by hyperlipidemia

    … heart failureRapid realist reviews for interventions to improve access to primary health care for vulnerable populationsAre ERECTILE DYSFUNCTION medications a gateway …

    … HelpED study: agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with ERECTILE DYSFUNCTION and their partners

    … HISTOMORPHOLOGICAL STRUCTURE AND FUNCTION WITH STEM CELLS IN A RAT MODEL OF NEURO VASCULAR ERECTILE DYSFUNCTION

    … HUMAN PLACENTAL STEM CELLS PROMOTE ERECTILE FUNCTION RECOVERY IN A RODENT NEURO VASCULAR ERECTILE DYSFUNCTION …

    … IMPROVES AORTIC ELASTIC PROPERTIES AND WAVE REFLECTIONS IN PATIENTS WITH ERECTILE DYSFUNCTION OF VASCULAR ORIGIN

    … in Cavernosal ARTERY Parameters According to Different Anatomic Sampling Locations During the Diagnosis of VASCULAR ERECTILE DYSFUNCTION Using Duplex Ultrasound

    … INTIMA MEDIA THICKNESS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

    … is associated with diminished levels of VASCULAR endothelial growth factor (VEGF) and its receptors in the penis: implications in the pathogenesis of erectile dysfunction …

    … LOW INTENSITY SHOCK WAVE THERAPY TO THE PENIS FOR VASCULOGENIC ERECTILE DYSFUNCTION-A RANDOMIZED SHAMCONTROLLED …

    … MELANOMA WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR USE AMONGST PATIENTS WITH ERECTILE DYSFUNCTION, PULMONARY HYPERTENSION AND …

    … MOTION ABNORMALITIES DURING STRESS ECHOCARDIOGRAPHY TESTING IN HYPERTENSIVE MEN WITH VASCULAR ERECTILE DYSFUNCTION

    … neuro VASCULAR bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction …

    … Nogo-B receptor inhibits penile corpus cavernosum VASCULAR smooth muscle cell apoptosis of rats with diabetic ERECTILE DYSFUNCTION by down-regulating ICAM-1

    … Nymphaea lotus Linn.(Nymphaeaceae) on N (ω)-nitro-L-arginine methyl ester-induced tissular oxidative damages and ERECTILE DYSFUNCTION in HYPERTENSIVE male …

    … of brachial ARTERY flow-mediated dilatation and carotid ARTERY intima-media thickness measurements may be a method to determine VASCULOGENIC erectile dysfunction

    … of Chicken Leg Bone Hydrolysates under Different Drying Conditions and Its Effectiveness on Improving ERECTILE DYSFUNCTION of Spontaneously HYPERTENSIVE  …

    … OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION: A MULTI-CENTER …

    … of monocyte count with carotid intima-media thickness, aortic stiffness and penile Doppler findings, in patients with VASCULOGENIC erectile dysfunction

    … of neuro VASCULAR bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in ERECTILE DYSFUNCTION after prostate brachytherapy

    … of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 261 Patients with Erectile Dysfunction: Endo VASCULAR Therapeutic Implications

    … of penile BLOOD flow including peak systolic velocity, end diastolic velocity and rigidity index: five patients of ERECTILE DYSFUNCTION experience in Shin Kong …

    … of the predictive value of testosterone levels and carotid femoral pulse wave velocity for major adverse CARDIO VASCULAR events in patients with erectile dysfunction

    … OF THE THERAPEUTIC TARGETING POTENTIAL OF MICRORNA-93 IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION

    … of VASCULAR Endothelial Growth Factor Receptors (VEGFR-1 and VEGFR-2) in Corpora Cavernosa (CC) Tissue in Diabetic Patients with ERECTILE DYSFUNCTION  …

    … ON PENILE MICRO VASCULAR ENDOTHELIAL REACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

    … on the CARDIO VASCULAR system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study

    … on: adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

    … on: Amino-Terminal Pro-C-Type Natriuretic Peptide is Associated with the Presence, Severity, and Duration of VASCULOGENIC Erectile Dysfunction

    … PEAK SYSTOLIC VELOCITY IS RELATED TO MAJOR ADVERSE CARDIO VASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

    … Penile Arterial Flow as an Adjunct to Increased Aortic Stiffness for Detecting Myocardial Ischemia During Stress Echocardiography in Erectile Dysfunction …

    … penile Doppler ultrasound findings and penile arterial insufficiency under percutaneous transluminal angioplasty for patients with erectile dysfunction

    … Plasma Asymmetrical Dimethylarginine (ADMA) as an Independent Predictor for the Presence of CARDIO VASCULAR Disease in Men with Erectile Dysfunction

    … Product Sciences: Articles; Ginsenoside Re Enriched Fraction (GS-F3K1) from Ginseng Berries Ameliorates Ethanol-Induced ERECTILE DYSFUNCTION via Nitric Oxide …

    … RELAXATION INDUCED BY INSULIN IN HUMAN CORPUS CAVERNOSUM AND PENILE ARTERIES IS IMPAIRED IN ERECTILE DYSFUNCTION.

    … relaxation of pudendal ARTERY and corpus cavernosum with increased VASCULAR sensitivity in spontaneously HYPERTENSIVE rats: Is it a new target for erectile dysfunction?

    … RETINAL ARTERIOLAR DIAMETER AND INCREASED RETINAL VENULAR DIAMETER IS ASSOCIATED WITH ERECTILE DYSFUNCTION

    … RISK FACTORS FOR CARDIO VASCULAR DISEASE ON THE CARDIOLOGISTIS’INTEREST IN ERECTILE DYSFUNCTION IN PATIENTS WITH …

    … Severe and Long-standing “Penile Angina” Are Additively Associated with Poor Exercise Performance in ERECTILE DYSFUNCTION Patients with HYPERTENSION

    … sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with VASCULOGENIC erectile dysfunction

    … SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with ERECTILE DYSFUNCTION Treated with Vardenafil

    … stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction

    … strategy of mesenchymal stem cell injection with VASCULAR endothelial growth factor gene therapy for the treatment of diabetes‐associated erectile dysfunction

    … tea influence expression of VASCULAR endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for VASCULOGENIC erectile dysfunction …

    … the Efficacy of Type 5 Phosphodiesterase Inhibitors to Relax Human Corpus Cavernosum and Penile Arteries from Diabetic Patients with Erectile Dysfunction

    … the erection hardness score to facilitate patient/partner-healthcare provider communication concerning ERECTILE DYSFUNCTION significance and management

    … to congratulate you and express my appreciation of the articles’ Understanding prostate cancer’,’Benign prostatic hyperplasia’and’Erectile dysfunction’in the journal of …

    … TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

    … type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with CARDIO VASCULAR risk factors and erectile dysfunction

    … value of nitric oxide, lipoprotein (a), and malondialdehyde levels in the peripheral venous and cavernous BLOOD of diabetics with erectile dysfunction

    … VARDENAFIL (LEVITRA®) ON ENDOTHELIAL FUNCTION OF CAVERNOUS AND BRACHIAL ARTERIES IN PATIENTS WITH ERECTILE DYSFUNCTION

    …  VASCULAR endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy and reverse venogenic erectile dysfunction …

    …  VASCULAR ENDOTHELIAL GROWTH FACTOR AND IMPROVED THE ERECTILE FUNCTION IN RATS WITH DIABETIC ERECTILE DYSFUNCTION

    [PP. 23.20] PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH RESISTANT HYPERTENSION

    [PP. 26.07] IMPACT OF VALSARTAN AND COMBINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE ON ERECTILE DYSFUNCTION IN PATIENTS WITH …

    015 Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary ARTERY Dysfunction in Young Lewis Rats

    021 Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction

    022 Cardiology Referrals, CARDIAC Risk Stratification and CARDIAC Catheterizations Procedures Generated From A High Volume Erectile Dysfunction …

    034 Penile BLOOD flow assessment using Doppler ultrasonography (PDUS) in ERECTILE DYSFUNCTION patients: A 10-Year Experiences at an International …

    034 Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction

    0389: Preference for ERECTILE DYSFUNCTION treatments in patients with chronic HEART failure

    045 Androgen Pattern and Endothelial Dysfunction in Patients With VASCULOGENIC Erectile Dysfunction

    0510: ERECTILE DYSFUNCTION (ED) and Chronic HEART Failure (CHF): correlation between severity of ED and the 6 minutes walk test

    076 Sexual dynamics as a critical part in the individualised management of men with ERECTILE DYSFUNCTION in UK

    104 Pluripotent Fetal Stem Cells for Treatment of the VASCULAR Factor of Erectile Dysfunction

    1066-196 ERECTILE DYSFUNCTION of VASCULAR origin is associated with generalized endothelial dysfunction

    1070: Up-Regulation of Nadph Oxidase Contributes to the ERECTILE DYSFUNCTION in Angiotensin II-Induced HYPERTENSIVE Rats

    1096-74 CARDIO VASCULAR risk factors as correlates of erectile dysfunction: Results of a survey in 71,503 men in Brazil

    1107 Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION by conventional and colour tissue Doppler echocardiography

    1116 Use of stromal VASCULAR fraction of adipose tissue in patients with VASCULOGENIC erectile dysfunction: Evaluation of clinical effectiveness and safety …

    112 Efficacy and Safety of Fixed Dose Combination of Amlodipine and Tadalafil in Both ERECTILE DYSFUNCTION and HYPERTENSION Patients Being Treated …

    1141-196 Effect of atorvastatin and sildenafil on endothelial function in patients with ERECTILE DYSFUNCTION and increased CARDIO VASCULAR risk

    115 Elevated plasma transforming growth factor-β1 level in patients with VASCULOGENIC erectile dysfunction

    1158 Arterial function and structure parameters are significantly impaired in pre-diabetic men with arterial HYPERTENSION and erectile dysfunction

    117 Erectile dysfunction: Looking for a BLOOD test to identify endothelial disease in patients consulting for impotence

    1198 ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR THE PRESENCE OF HIGH RISK CORONARY ARTERY CALCIFICATION

    120 CARDIO VASCULAR parameters changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: A first study with sildenafil 50mg and vardenafil 10mg

    1252: Association Between ERECTILE DYSFUNCTION and Coronary ARTERY Disease. Role of Coronary Clinical Presentation and Extent of Vessel Involvement …

    1282: VASCULAR Damage as Risk Factor for Lower Urinary Tract Symptoms and Erectile Dysfunction

    1324 IS THERE A CONCORDANCE BETWEEN CAROTID AND CAVERNOUS ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH ERECTILE DYSFUNCTION …

    1326: ERECTILE DYSFUNCTION as a Predictor of Coronary HEART Disease in Aging Men: Prospective Results from the Massachusetts Male Aging Study

    1333: Association of ERECTILE DYSFUNCTION and Subsequent CARDIO VASCULAR Disease

    1338: The Impact of VASCULAR Risk Factors on Penile Hemodynamics in Men with Erectile Dysfunction

    1340: ERECTILE DYSFUNCTION Predicts Extension of Coronary ARTERY Disease by Angiography in Acute Coronary Syndromes. The Dead Goose Study

    1351: Erectile dysfunction, HEART failure and pharmacology: Keeping the patient safe by providing effective treatment

    136 Human Cord BLOOD Endothelial Colony Forming Cells Induce Significant Recovery of Severe ERECTILE DYSFUNCTION in Obese Type II Diabetic Rats

    137 Superparamagnetic Iron Oxide Nanoparticle Targeting of Adipose Tissue-Derived Stem Cells in Diabetes-Associated Erectile Dysfunction

    1533 COMPARISON OF RATES AND RISK FACTORS FOR DEVELOPMENT OF ERECTILE DYSFUNCTION AFTER RADICAL OR PARTIAL NEPHRECTOMY

    1620: The Comparison of HYPERTENSION Prevalence Rates Between Men with and without Erectile Dysfunction: Evidence From A Large National Managed …

    1638: ERECTILE DYSFUNCTION and Oxidative Stress-Media Ted Cavernosal Cell Death in Spontaneously HYPERTENSIVE Rats

    17: Female Partners of Men with ERECTILE DYSFUNCTION Treated with Sildenafil Citrate Report Greater Satisfaction and Enjoyment from Sexual Intercourse: A Multicenter …

    176 RELATIONSHIP BETWEEN CORONARY ARTERY DISEASE, VASCULOGENIC ERECTILE DYSFUNCTION AND ENDOGENOUS SERUM …

    1804 PENILE RE VASCULAR IZATION IN VASCULOGENIC ERECTILE DYSFUNCTION: LONG-TERM FOLLOWUP

    18F-FLOURIDE UPTAKE IN PENILE ARTERIES: DOES IT REPRESENT ATHEROSCLEROTIC BASIS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

    18F-fluoride positron emission tomographic imaging of penile arteries and erectile dysfunction

    18F-fluoride uptake in Penile Arteries and Erectile Dysfunction

    207 15 ERECTILE DYSFUNCTION AN AGE-INDEPENDENT PREDICTOR FOR CARDIO VASCULAR EVENTS?

    208 Low-Intensity Shock Wave Therapy for Treatment of VASCULOGENIC Erectile Dysfunction: Phase 1 Results of the Dornier Aries in the First United States …

    208 Relationship between ERECTILE DYSFUNCTION and coronary anatomy in patients with ischemic HEART disease debut

    209 SEVERE ERECTILE DYSFUNCTION AS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE

    213 Nrf2 activation improves both hyperpolarization-and NO-mediated responses in penile vasculature from patients with erectile dysfunction

    2132 IMPACT OF RENAL TRANSPLANT ON VASCULOGENIC AND NEUROGENIC DETERMINANTS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

    221 Comparing ERECTILE DYSFUNCTION with Traditional VASCULAR Risk Factors in the Prediction of Coronary ARTERY Disease in Patients Presenting with Chest Pain

    225 VARDENAFIL VERSUS SILDENAFIL IN MEN WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK FACTORS: A SUBGROUP ANALYSIS

    249 Micro VASCULAR changes in erectile dysfunction

    267 Pericyte Number and Micro VASCULAR Density Change in Corpus Cavernosum of ERECTILE DYSFUNCTION Rat Models

    285 VASCULAR damage as risk factor for lower urinary tract symptoms and erectile dysfunction

    287 Erectile Dysfunction, Penile Atherosclerosis and Coronary ARTERY Disease in HEART Transplant Recipients

    294 ERECTILE DYSFUNCTION associates own” arterial phenotype”defined by greater atherosclerotic burden, arterial stiffness and thickness and VASCULAR reactivity …

    353 THE PATHOGENETIC BASIS FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH CARDIO- VASCULAR RISK FACTORS

    355 CARDIORESPIRATORY FITNESS IN MEN WITH ERECTILE DYSFUNCTION

    380 Penile Doppler, Vendys® and SphygmoCor® in the Diagnosis of VASCULAR Erectile Dysfunction: Evaluation and Development of a Diagnostic …

    385 Losartan Preserves Erectile Function by Suppression of Cavernosal Fibrosis and Corporal Veno-Occlusive Dysfunction in Diabetic Rats

    417 Spontaneously Diabetic Torii Fatty Rats do not Show ERECTILE DYSFUNCTION Under High-Blood Glucose Levels in a Preliminary Study: The Importance of Model …

    454 Inverse correlation between testosterone and CARDIAC function in HEART failure patients with erectile dysfunction. Is there a resistance to testosterone?

    462 ERECTILE DYSFUNCTION AS A SUBROGATE MARKER OF CORONARY ARTERY DISEASE

    5 ERECTILE DYSFUNCTION IN ThE CArDIoloGy PrACtiCe

    52 Do the HEART transplant patients ask about their ERECTILE DYSFUNCTION to the nurse?

    530 Early start of oral sildenafil 100mg for ERECTILE DYSFUNCTION after robotic assisted laparoscopic radical prostatectomy: Preliminary results from …

    54 DOES ERECTILE DYSFUNCTION IMPROVE CARDIO VASCULAR DISEASE RISK PREDICTION?

    543Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION and their partners

    580 Family history regarding CARDIO VASCULAR disease and diabetes and ERECTILE DYSFUNCTION in patients with coronary ARTERY disease

    5930Correlation of brachial flow-mediated vasodilatation and ERECTILE DYSFUNCTION severity and association with coronary ARTERY disease among CAD patients …

    670 Percutaneous angioplasty of internal pudendal arteries in the treatment of ERECTILE DYSFUNCTION not responsive to pharmacological therapy. Our initial …

    676 Penile re VASCULAR ization surgery in patients with diabetic erectile dysfunction: long term results

    689: Correlation between Penile Doppler Findings and C-Reactive Protein Levels in Patients with ERECTILE DYSFUNCTION of VASCULAR Origin

    694Is ERECTILE DYSFUNCTION an indicator for increased risk of coronary HEART disease or stroke?

    695Association between ERECTILE DYSFUNCTION and coronary ARTERY disease. Role of coronary clinical presentation and extent of vessel involvement. The …

    697: Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of> 44,800 Patients in Clinical and …

    699 High BLOOD pressure accelerates penile arterial insufficiency in young ERECTILE DYSFUNCTION patients. A window of opportunity for preventing VASCULAR  …

    706 Influence of socioeconomic factors on the presence and intensity of ERECTILE DYSFUNCTION in men with coronary ARTERY disease

    707 Influence of testosterone deficiency on the BLOOD -pressure increase, in aortic stiffness, of the ERECTILE DYSFUNCTION patients

    733 ERECTILE DYSFUNCTION in spontaneously HYPERTENSIVE rats is accompanied by corporal endothelial dysfunction and remodelling: Cause or consequence …

    750 CORRECTION OF DIABETIC ERECTILE DYSFUNCTION WITH ADIPOSE DERIVED STEM CELLS MODIFIED WITH THE VASCULAR ENDOTHELIAL …

    864: ERECTILE DYSFUNCTION and Coronary HEART Disease

    909 SOCIODEMOGRAPHIC AND PSYCHOLOGICAL CORRELATES ASSOCIATED WITH ERECTILE DYSFUNCTION AMONG HYPERTENSIVE PATIENTS

    919 ERECTILE DYSFUNCTION DOES NOT INDEPENDENTLY PREDICTOR CARDIO VASCULAR DEATH: DATA FROM THE VITAMINS AND LIFESTYLE …

    921 INCIDENT HYPERTENSION AND RISK OF SUBSEQUENT ERECTILE DYSFUNCTION IN MEN WITH TYPE 1 DIABETES

    952 CORRELATION OF THE ERECTILE DYSFUNCTION WITH LESIONS OF CEREBRO VASCULAR ACCIDENTS

    953 PENILE DOPPLER FINDINGS OF ARTERIAL FLOW IN RELATION TO VASCULAR RISK FACTORS IN PATIENTS WITH ERECTILE DYSFUNCTION

    A case of ERECTILE DYSFUNCTION and risk factors for coronary ARTERY disease

    A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II

    A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction

    A Computational Model for the Exploration of VASCULOGENIC Erectile Dysfunction

    A cross-sectional study of HYPERTENSIVE outpatients to determine the necessity of asking about ERECTILE DYSFUNCTION symptoms

    A Letter to the Editor Regarding the Original Article by Mulhall et al: Utility of Tacrolimus (FK506) trough level for the Prevention of Erectile Dysfunction

    A multidisciplinary approach to assess ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients

    A Natural Approach to ERECTILE DYSFUNCTION that Improves VASCULAR Health

    A new parameter in the diagnosis of VASCULAR ERECTILE DYSFUNCTION with penile Doppler ultrasound: cavernous ARTERY ondulation index

    A novel experimental model of ERECTILE DYSFUNCTION in rats with HEART failure using volume overload

    A Population Survey to Study the Association Between Microalbuminuria and ERECTILE DYSFUNCTION Among Patients With CARDIO VASCULAR Risk Factors: Interaction with …

    A population-based study on the association between rheumatoid arthritis and erectile dysfunction

    A population-based, longitudinal study of ERECTILE DYSFUNCTION and future coronary ARTERY disease

    A prospective randomised crossover trial on the effect of vardenafil 10mg on BLOOD pressure in patients with ERECTILE DYSFUNCTION who receive concomitant …

    A review of hypogonadism and ERECTILE DYSFUNCTION among HIV-infected men during the pre-and post-HAART eras: diagnosis, pathogenesis, and management

    A Review on ERECTILE DYSFUNCTION Among HYPERTENSIVE Patients on Pharmacotherapy

    A simple noninvasive test to detect VASCULAR disease in patients with erectile dysfunction: a novel method

    A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with VASCULOGENIC erectile dysfunction

    A state of art review on vardenafil in men with ERECTILE DYSFUNCTION and associated underlying diseases

    A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction

    A study of the VASCULOGENIC and endocrinal factors in cases of metabolic syndrome suffering from erectile dysfunction

    A systematic approach to ERECTILE DYSFUNCTION in the CARDIO VASCULAR patient: a Consensus Statement–update 2002.

    A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

    A systematic review of the long-term efficacy of low-intensity shockwave therapy for VASCULOGENIC erectile dysfunction

    A young man with position-dependent erectile dysfunction: diagnostic work-up and interventional therapy of an arteriovenous malformation

    AB006. ERECTILE DYSFUNCTION (ED) as a marker for CARDIO VASCULAR diseases (CVD)

    AB008. The link between ERECTILE DYSFUNCTION (ED) and CARDIO VASCULAR disease (CVD): what a urologist needs to know

    AB039. Metabolic syndrome/cardio VASCULAR disease and ERECTILE DYSFUNCTION (ED)

    AB130. The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION population

    AB145. Comparison of the prevalence of CARDIO VASCULAR risk factors between young male and the elderly with erectile dysfunction

    AB174. ERECTILE DYSFUNCTION and usage of PDE5-inhibitors in male partner of infertile couple

    AB231. The relationship between CARDIO VASCULAR disease and ERECTILE DYSFUNCTION among aged men in Southern China

    AB67. Molecular mechanisms of Chinese herbal formula Shuganyiyang (SGYY) capsule of treating arteriogenic ERECTILE DYSFUNCTION (ED) in a rat model

    Abnormal insulin signaling: early detection of silent coronary ARTERY disease-erectile dysfunction?

    Accounts of the impact of ERECTILE DYSFUNCTION on heterosexual couples from men seeking erectogenic treatment and their partners

    Activation of the ET‐1/ETA pathway contributes to ERECTILE DYSFUNCTION associated with mineralocorticoid HYPERTENSION

    Acute effect of sildenafil on inflammatory markers/mediators in patients with VASCULOGENIC erectile dysfunction

    Adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

    Adjustments for smoking, diabetes, HYPERTENSION and coronary HEART disease do not fully explain the age-related increase in prevalence of erectile dysfunction

    Aetiology and management of male ERECTILE DYSFUNCTION and female sexual dysfunction in patients with CARDIO VASCULAR disease

    Age-matched cavernous peak systolic velocity: a highly sensitive parameter in the diagnosis of arteriogenic erectile dysfunction

    Alfuzosin attenuates ERECTILE DYSFUNCTION in rats with partial bladder outlet obstruction

    All men with VASCULOGENIC ERECTILE DYSFUNCTION require a CARDIO VASCULAR workup

    Alteration of Redox Homeostasis and Protein Expression of Constitutive Nitric Oxide Synthases Contributes to ERECTILE DYSFUNCTION of HEART Failure Rats

    Alterations in Endothelial Nitric Oxide Synthase and RhoA/ROCK are Associated with ERECTILE DYSFUNCTION in Angiotensin II-induced HYPERTENSIVE Rats

    Alterations in microRNA expression in a murine model of diet‐induced VASCULOGENIC erectile dysfunction

    Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of VASCULOGENIC erectile dysfunction

    Amiodarone, ERECTILE DYSFUNCTION drugs, and non-arteritic ischemic optic neuropathy

    An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction

    An investigation into the link between vitamin D status, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors in ageing men in New Zealand: a thesis presented in partial …

    An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses

    Analysis of related factors for ERECTILE DYSFUNCTION in middle-aged and elderly patients with HYPERTENSION [J]

    Androgen deficiency, ERECTILE DYSFUNCTION and chronic micro VASCULAR complications in male diabetic patients

    Androgens, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in type 2 diabetes

    VASCULAR -re VASCULAR ization-pudendal-artery-atherosclerotic-disease”>Angiography and endo VASCULAR re VASCULAR ization of pudendal ARTERY atherosclerotic disease in patients with medically refractory erectile dysfunction

    Angiopoietin-1-induced VASCULAR remodeling and angiogenesis: Could it be an effective treatment for atherosclerotic ERECTILE DYSFUNCTION and obesity?

    Angiotensin II increases corpus cavernosal contractility and oxidative stress in partial bladder outlet obstructed rabbits: relevance to erectile dysfunction

    Angiotensin Receptor Blockers for ERECTILE DYSFUNCTION in HYPERTENSIVE Men: A Brief Meta-Analysis of Randomized Control Trials

    Animal models of ERECTILE DYSFUNCTION (ED): potential utility of non-human primates as a model of atherosclerosis-induced VASCULAR ED

    Antihypertensive Drug Therapy and Erectile Dysfunction

    Antihypertensive drugs and ERECTILE DYSFUNCTION as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers

    Antihypertensive therapy causes erectile dysfunction

    Antihypertensive treatment and ERECTILE DYSFUNCTION in a cohort of type II diabetes patients

    Antiplatelet (aspirin) therapy as a new option in the treatment of VASCULOGENIC erectile dysfunction: a prospective randomized double-blind placebo-controlled study

    Aortic stiffness and carotid intima media thickness are associated with penile Doppler findings in patients with VASCULOGENIC erectile dysfunction

    Aortic/penile index is a marker of occult coronary ARTERY disease in middle-aged HYPERTENSIVE patients with erectile dysfunction

    apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. Journal of Urology 172: 2347-2349, No. 6, Part 1, Dec 2004 800995972

    Application and value of color Doppler ultrasonograghy in the diagnosis of VASCULOGENIC erectile dysfunction

    Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of VASCULOGENIC erectile dysfunction

    Application of colour Doppler ultrasonography in the diagnosis of VASCULOGENIC erectile dysfunction

    Approach to ERECTILE DYSFUNCTION in Patients with HYPERTENSION and Coronary ARTERY

    Approach to ERECTILE DYSFUNCTION in patients with